• 검색 결과가 없습니다.

Korean Chemical Engineering Research

N/A
N/A
Protected

Academic year: 2021

Share "Korean Chemical Engineering Research"

Copied!
7
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)Korean Chem. Eng. Res., Vol. 43, No. 1, February, 2005, pp. 103-109. ëÇ ·<[

(2) ‡ƒ% |ð +£ß £ÃÛ£ Lð. oSL <·< ¿› ðÃG <<D ‹û* †. ŸD¬H/ àê¬H @·dHàHê 100-715 ŠÖQ OC 1Ÿ 3Í 26 *õ§¬H/ àê¬H dà·@àHz 120-749 ŠÖQ ЬéC UôŸ 134 (2004¸ 11ö 4³ [¤, 2005¸ 1ö 13³ >). Effect of Environmental Factors on the Growth of Rabbit Oral Keratinocytes Moon-Young Yoon, Hee-Jung Park, Doo-Hoon Lee, In-Keun Jang, Jung-Keug Park† and Woo-Sik Kim* Department of Chemical and Biochemical Engineering, Dongguk University, 26, 3-ga, Pil-dong, Chung-gu, Seoul 100-715, Korea *School of Chemical Engineering and Biotechnology, Yonsei University, 134, Sinchon-dong, Seodaemun-gu, Seoul 120-749, Korea (Received 4 November 2004; accepted 13 January 2005). ß È. Ù CãYL )§¯‹ ~- Ú ³ó Š ör, §¯ ßÑ Âj2 h ¯É‹ Ñ ¬K õCõ T75-ñ¶) ¿õ ÄGñ ¤}GŒ. ً CãYLÆ)s í(biopsy)K á 6?U(trypsin) Ás-örs «ÄGñ 0.25 cm YL Æ)k³z 1.92±0.59 10 í‹ YL )§¯õ ¡¤O ¤ ÀɌ. ¡¤K YL )§¯õ 50 mg/L BPE(bovine pituitary extract), 5.0 µg/L EGF(human recombinant epidermal growth factor), 0.15 mM Ca s WKK K-SFM(keratinocyte serum free medium)s 10 mL ÄGñ ³ó ŠK ’ê 8³ OÑ ŠÄ,,

(3) Ñ §¯Í ¯d(confluent)Gj  ßG Ê ÍQÑo 2.45³«ÉŒ. ³ó ŠK §¯õ ¡¤K á (ÜÍ, (z), ƒÍí ÜÍÍ )§¯ ßÑ Âj 2 s Æ GŒ.

(4) ‰ƒÍ (2 §¯ ßÑ z_J¯ Áêõ ÷,Ê,

(5) ‰ ‰Í ÍWÑ ¶ §¯ ßo à ¡dÍ ÇɌ. (z)Í ÍWÑ ¶ §¯ ßo ÝGÊ,  ‰Í ÍO¤´ §¯ ßo ÍGk 2.0 mMъ MJjõ ÷Ɍ. « k³ Ù CãYL )§¯õ T75-ñ¶)¿õ ÄGñ ŠG2  Î 50 mg/L BPE, 5.0 µg/L EGF, 2.0 mM Ca s WKK K-SFMs 10 mL ÄG2 ÆQ« Íß JYGÊ ÍQÑo 1.32³« Ɍ. «6K õC’ê2 á YL O 4n¶ )z, ÎL Ù ¯Ñ ÊéG2 )§¯ Šs .K à_íè«÷ @ íä, ’ªÑ KÄK _Ýõ fàO ak³ 0êŒ. 2. 6. 2+. 2+. Abstract - Isolation and primary culture technique of rabbit oral keratinocytes, and the study for effect of environmental factors on the cell growth were carried out in T75-flask. 1.92±0.59×106 viable cells were isolated by trypsin enzymatic digestion method from 0.25 cm2 biopsy of rabbit oral mucosa. Primary culture with 10 mL of K-SFM containing 50 mg/L BPE, 5.0 µg/L EGF and 0.15 mM Ca2+ showed confluence after 8 days and doubling time was 2.54 days. Effect of medium types, medium volume and supplement types on the cell growth was investigated after the cultured keratinocytes had been harvested from primary confluence. Serum addition showed adverse effect and the increase of serum concentration didn’t have an effect on the cell growth. The increase of medium volume decreased the cell growth. The increase of calcium concentration increased the cell growth and 2.0 mM was optimum value. In conclusion, when rabbit oral keratinocytes was cultured in T75-flask, the most effective conditions was to use 10 mL of K-SFM containing 50 mg/L BPE, 5.0 µg/L EGF and 2.0 mM Ca2+, and doubling time was 1.32 days. This study can provide the useful informations to develop a process and design a bioreactor for the culture of keratinocytes in human body like skin and cornea, as well as mucosa. Key words: Keratinocyte, Mucosa, Medium Supplements, Calcium, Environmental Factors, Serum-free Medium. † To. whom correspondence should be addressed. E-mail: [email protected]. ‡. « øéo õ§¬0/ 6ÎR /¤‹ _¸s ,Ä/ñ ·ÊæÉ5nŒ. 103.

(6) 104. 1.. C «. Oéöáž_ö«åö߯öá_ö6ÎR. gã58

(7) Žê ~tъ gã  5 ÜŠs fMG2  Î p.K gãYL « tDæ

(8) «6K  Î )zõ «RG2 a « ³äJ¯ j0ör«Œ[1, 2]. 6÷ «6K )zÆ)s «RO  Î )z á֋ gÆQ DDs K(GD AéÑ YLÆ)ê á0 Jk³ kÎ ŒíÊ ,)§¯Q õ’§¯Q‹ DÊÄ AéÑ ) z ɐ‹ U8« ¬³ K(êŒ[3]. 6‚³ «Rj «Rê ) zÆ)o ¥« ɶM÷ 1« ÿ ¤‰ ÀD AéÑ hÉÑj2 z JYO ¤ Àk‚³ YL s j0GD .gŠ2 YL Æ)s «RG2 a« « J«¶ O ¤ ÀŒ[4, 5]. YLÆ)o hÉ ÉU ‹ as ÄG2 a«

(9) ò Mzäs è@Qÿ( :D AéÑ Íß « J«(O, ÉD U ъ p.K YLÆ)s ¾´ 2 ao M‹ ‚ÍDG‚³ «Ñ ¬K ¬8k³ ᯋ gãъ 

(10) ‹ YLÆ)s ¾´ á YL§¯õ ~-Gñ ŽÑŠ  ß QE 3óòJ¯ ¯àYLÆ)s fÆG2 Æ)àH D¬s ÄG 2 a« Íß àÆ)K ör«¶ O ¤ ÀŒ[6-9]. K, gãYL )§¯2 )z )§¯ÝŒ  ß‰Í uíÊ ŽÑŠ @ÊD Ñ« LÊ Æ)í(biopsy) áÑ tõ ´L ¤ Àk‚³ )z j 0õ .K ¯à )Æ) §¯òk³Š Ùé « Œ[10]. «6K ¯àYLÆ)s fÆGD .gŠ2 ŽÑŠ YL )§¯õ ¬

(11) RQ ¤ À2 Šh  -+Ñ ¬K õgÍ Ž}æ´t G2) 4) «6K õg2 ÂWK =«Œ. )§¯õ ŠGD .Gñ 3T3 šKH§¯õ feeder layer³ ÄG2 a« ³äJ¯)[11], « öro ŽÑŠ 5  ܊, ÙéJ¯ §¯Š í0 Ú Œñ K K éfYËs õgG2  ÎÑ ñ6 Í( HŸæ2 ¯ÉËs è@Q ¤ À´Š «6K feeder layer‹ Äs )GD .K ñ6 Í( Œñ )§¯ ŠörË« íèæ´ fŒ. , ¶n(collagen), )³ •˜(fibronectin), ¶Âr(laminin) ço §¯Ž D0(extracellular matrix) ъ èŽê ~ÉËs Š,

(12) Ñ ªG2 ör[12], ŠÄ (‹  ‰õ ¡dQÿ2 ör[13], conditioned medium «÷ complex biologic extractsõ ÄG2 ör[14], D‹ Í( örËs H YGñ ÄG2 ör[15] Ù« Àk÷ «6K örËo ( @í HJ¯ +

(13) ъ §¯‹ DDs ÝD .K Šör«¶ O ¤ À Ê §¯õ ¡¤K á ÄGD .K IJk³2 «6K örË« W  fJ «M÷ kÎ ‚sK örË«Œ. á õgъ2 T75-ñ¶)¿Ñ Š Ù gãYL )§¯õ U¾  ßQÿD .Gñ, )§¯ ~- Ú ³ó Šê h ¯ÉÑ ¬K s Æ K á ~‹GŒ. h ÆQs -+GD .Gñ (ÜÍ, ( ƒÍíê (z)Ñ ¬K s Æ GÊ, ( ƒÍío DáJk³ Äæ2

(14) ‰, BPE Q EGF, Ok³ ÆQËs fKGŒ. 2.. /÷ Z tà. ëÇ ·`[

(15) ‡ƒ% Ï÷ Z Çs{Ü Ù gãYL )§¯õ ~-G2 QóÑ ¬Gñ Fig. 1Ñ Å. GŒ. Ù2 0Úà ¢+ 4Ù³ 11cê è 2.5 kg å j‹ ¤s ÄGÊ, ً gã YLÆ)s ®1ÃU( \: 1 ¯W, 1fu(c))k³ £~¾ Ž4cÊ ]@f(Antibiotic Antimycotic, Invitrogen. Cat.# 600-5240AG)Í 20 µl/mL³ ¯Wê DMEM(Invitrogen Cat.# 12800-017)Ñ “´ -ß5‰³ ÒäGŒ. 2-1.. Ÿ¤@¤ C43× C1ƒ 2005 2. + -. ,. Fig. 1. Schematic diagram of procedures to isolate oral keratinocytes from normal rabbit mucosal segment. Mucosal segment, Washing with 70% ethanol and PBS, Incubation for 16 hours at 4 oC in dispase solution, Separation of epidermis and dermis, Chopping and trypsinization, Isolation of 7 epithelial cells, Culture in T75-flask. .. / 1. 0. gã YLÆ)s 70% Ñ!9³ §tGÊ ŒQ Antibiotic Antimycotic 200 µlQ Gentamycin(Invitrogen. Cat.# 600-5710 AD, 0.1 µl/mL) 10 µl Í Ë´À2 10 mL PBS(phosphate buffered saline) ³ 3¡ §tK á 8ê ¤¬Ä Í.³ ,)Q )G(ö@ z.õ £~¾ fMGÊ, 2.4 U/mL‹ l s Í, protease(dispase; Sigma Cat.# P-3417) Ä UÑ “Ê 4 Cъ 16QÑ s-K á ¯¹(forceps)s «ÄGñ )@ê ,)@s ~-GŒ. )@s 8êÄ ¤¬ Í.õ «ÄG ñ §Gj Éñ á 0.05% T?U(trypsin, Sigma Cat.# T-4799)ê 0.01% EDTAõ WKK PBS ÄUÑ “Ê 37 Cъ 10~Ñ s-G Ê 10%(v/v) FBS(fetal bovine serum, Invitrogen Cat.# 12484-028) Í WKê DMEM (Ñ ;Š 1,000 rpmъ 5~ ò[~-GŒ. ò[~- á ÙUo `-Ê ŒQ K-SFM(keratinocyte serum free medium, Invitrogen, Cat.# 320-7005PJ) Dá ( 10 mLõ ƒÍK á )cª(pipetting)s u 5~ YQGñ §¯õ ~-GŒ. @§¯ ª ¤(viable cell count)2 PBSÑ õ¯ 4.0 g/L‹ T?¶ P(trypan blue, Sigma Cat.# T-5526) ÄUk³ +K á hemocytometerõ « ÄGñ ¤}GŒ. ¡¤K §¯2 Ca ‰ 0.15 mM, antibiotic antimycotic ]@f‹ ‰õ 10 µl/mL, ( ƒÍí(supplement)³ BPE(bovine pituitary extract, Invitrogen Cat.# 13028-014) 50 mg/LQ EGF(human recombinant epidermal growth factor, Invitrogen Cat.# 10450-013) 5.0 µg/L« WKê K-SFMs ÄGñ ŠGÊ, ( 10 mL s WKK T75-ñ¶)¿(,

(16) J 75 cm )Ñ [ÜGñ 2³ KŒ (õ Ghg c

(17) Š 37 C³ K(æ2 CO ¯Ÿ}«ÑŠ ŠGŒ. 2-2. { У, óKW У, ÇãØ Z { ˇ£ Lð Ù gãYL )§¯õ  ßQÿ2) (Ü͋ s Æ. GD .Gñ Ë K-SFM Dá (Ñ BPE 50 mg/L, EGF 5.0 µg/L, 1.5 mM Ca õ ƒÍK  Î, Ì MEM (Ñ FBS 10%(v/v) ƒÍ K  Î, Í DMEM (Ñ FBS 10%õ ƒÍK  Î, Î Ham’s F-12 (Ñ FBS 10% ƒÍK  Îõ WGGñ ÝIŒ. (ƒÍí‹ Ü ÍÑ ¬K s Æ GD .Gñ Ë K-SFM Dá (ъ Š K  Î, Ì K-SFM Dá (Ñ ƒÍí³ 1.5 mM Ca ê FBS 10%õ ƒÍK  Î, Í K-SFM Dá (Ñ ƒÍí³ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca õ ƒÍK  Î, Î K-SFM Dá (Ñ ƒÍí o. o. 2+. 2. o. 2. 2+. 2+. 2+.

(18) CãYL )§¯  ßÑ Âj h ¯É‹ . ³ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca ê FBS 10%õ ƒÍ K  ÎõWGGñ ÝIŒ.

(19) ‰ƒÍ‹ sÆ GD .Gñ K-SFM Dá (Ñ BPE, EGF, Ca s “( :Ê FBS 0, 5, 10, 15, 20%. ‰³ ƒÍ ŠGñ Ù gãYL )§¯  ßs WGGŒ.  ‰‹ s Æ GD .Gñ 50 mg/L BPE Q 5.0 µg/L EGF õ WKK K-SFM (Ñ Ca ‰õ 0.1, 0.5, 1.0, 1.5, 2.0, 2.5 mM« 扴 ÆQK á §¯ ßs WGGŒ. D‹ HÇ Y×ъ (z)2 10 mL³ GŒ. (z)Ñ ¬K o T75-ñ¶)¿ Ñ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca WKK K-SFM (õ ÎÎ 10, 15, 20 mL 扴 ÆQGñ ŠK á §¯ ßs WGGŒ. HÇ  Î ŠÆQo ³ó Š á ¡¤K §¯õ cm ¢ 3.5 10 í ‰³ Î΋ (õ WKGÊ À2 T75-ñ¶)¿ Ñ [ÜGñ 37 C³ K(æ2 CO ¯Ÿ}«ÑŠ 4³ ŠK á hemocytometerõ «ÄGñ @§¯ ª¤(viable cell count)õ ¤}G Ê, (G cD2 2³³ GŒ. 2+. 2+. 2+. 2+. 2. 3. o. 2. 3.. ûG Z +{. ëÇ ·`[

(20) ‡ƒ% Ï÷ Z Çs {Ü Ù³z gãYLÆ)s ¾´ á YL )@Os ~-Gñ T?Uk³ Ás- K á õJ¯ )cª(pipetting)k³ 0.25 cm ‹ YL Æ)k³z 1.92±0.59 10 í‹ YL )§¯õ ¡¤O ¤ ÀɌ. ¡¤ê §¯õ 50 mg/L BPE, 5.0 µg/L EGF, 0.15 mM Ca s WKK K-SFMs ÄGñ 10 mL 2³KŒ (õ Ghgc

(21) Š ŠK ’ê 8³ OÑ Š,

(22) Ñ ¯d(confluent)æj  ßG Œ. Fig. 22 ³ó Šê_ъ ŠQÑÑ !¶ §¯ ßs Ý D .Gñ H Gъ Öo ,s ÷ a«Œ. Š ð DÑ2  ß« uíj «P´(( :I(O, Š 4³ áz2 u ñ ‰³  ßGŒ. ŠU0 á  §¯¤õ +_K ’ê ðD [Ü

(23) « 2.6 10 í‹ §¯¤³z Š 8³ Ÿ8 (2.5±0.3) 10 í‹ §¯¤³ RGñ ðDÑ Wg u 9.6 ‹  ßs ÷É 3-1.. 2. 6. 2+. 5. 6. Fig. 2. Light microscopic pictures for the primary culture of normal rabbit oral keratinocytes at Day 1 (A), Day 2 (B), Day 4 (C) and Day 8 (D). After the keratinocyte was isolated from mucosal segment, 3.5×103/cm2 of cells were inoculated into T75-flask with 10 mL of K-SFM containing 50 mg/L BPE, 5.0 µg/L EGF and 0.15 mM Ca2+. Photographs at a magnification of ×100 were taken with a camera attached to a phase-contrast microscope. Bar indicates 200 µm.. 105. Ê, ÍQÑ(doubling time)o 2.45³«Œ. Daniels Ù[16]‹ ÝÊ Ñ ‹G

(24) hъ é ÄGÊ À2 )§¯ ŠörÑ ¬K Æ ÑŠ 3T3 šKH§¯õ feeder layer³ ÄGñ

(25) ‰« WKê Ê ‰  (õ ÄG2 ör« 53%³ ÷

(26) Ê, I ‰  ‹ å

(27) ‰ (õ ÄG2 ör« 43%³ ÷

(28) Œ.

(29) ‰s W KK (õ ÄG2  Î2

(30) ‰‹ 1òk³ ¯K ÇÍéf ً ñ6 ÞÛK éfõ è@Q ¤ Àk‚³ é å

(31) ‰ ( õ ÄGs2 ök³ MhGÊ ÀŒ. I ‰ s WKK å

(32) ‰ (‹ Yo feeder layerõ ÄG2  Î݌ §¯ ŠÑ YÒG2  ÎÍ QÊ §¯‹  ß‰Í .sŠ ³ó ŠDÑ« 2c _‰ U1Œ2 a«Œ. 6÷ á õgъ2 ³ó ŠDÑ« 8³³ ÷

(33) 2) « ’ê2 (ÜÍ, ƒÍí ÜÍ,  ‰ ŽÑ ‰ ŠÄD‹ ,

(34) J ÍQ (z) ÝQ ço h ¯ÉÑ ‹ K k³ 0æÊ, «: ¯ÉË« §¯‹ autocrine èn Ñ ‹K «ˆ¯‹ ‰õ ÍQEŠ §¯ ßs

(35) Ï ñ,QZD Aék³ 0êŒ. «: h ¯Éˋ Ñ ¬g Ö

(36) gJ k³ Æ GD .Gñ ³ó ŠK §¯õ ¡¤Gñ h ¯É‹  Ñ ¬K ÍJ¯ Y×s ª ,}GŒ. 3-2. { У, óKW У, 5ø, ÇãØ Z { ˇ£ Lð ً gãYL )§¯õ  ßQÿ2) å

(37) ‰‹ Dá (¯ K-SFMÑ ƒÍí³ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s WKK (Q

(38) ‰« WKê Í( ( Ü͋ s Æ G Œ. Fig. 3ъ ÷ asF K-SFMÑ ƒÍís WKK  ÎÍ MEM, DMEM, F-12 (Ñ

(39) ‰s ƒÍK  Î݌ 37.5%, 106.3%, 112.9%³ §¯ ß« ÍGŒ. « ’ê³z K-SFM Dá (Ñ BPE, EGF,  -Ê

(40) ‰ ƒÍÍ §¯ ßÑ ´¥ s Âj2( <4ÝD .K Y×s G Œ. K-SFM Dá (ъ ŠK  ÎÑ Wg K-SFM Dá ( Ñ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s ƒÍK  ÎÍ 2+. 2+. Fig. 3. Effect of media types on the growth of rabbit oral keratinocytes. After the cultured keratinocyte had been harvested from primary confluence, 3.5×103/cm2 of cells were inoculated into T75-flask with 10 mL of each media. Supplements were used at the concentrations of 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca2+ and 10% (v/v) FBS. Cell number was counted after 4 days of culture. Korean Chem. Eng. Res., Vol. 43, No. 1, February, 2005.

(41) Oéöáž_ö«åö߯öá_ö6ÎR. 106. Fig. 4. Effect of supplements on the growth of rabbit oral keratinocytes. After the cultured keratinocyte had been harvested from primary confluence, 3.5×103/cm2 of cells were inoculated into T75-flask with 10 mL of K-SFM containing different supplements. Supplements was used at the concentration of 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca2+ and 10% (v/v) FBS. Cell number was counted after 4 days of culture.. §¯ ß« Í GÊ, 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s ƒÍK K-SFMÑ

(42) ‰s

(43) ƒÍK  Î2 §¯ ß« 1 ¾s 33.3% ÝGŒ. K-SFM Dá (Ñ ƒÍí³ BPEQ EGF õ fŽGÊ 1.5 mM Ca ê 10%(v/v)

(44) ‰Os ƒÍK  Î2 BPE, EGF, s WKK (Ñ Wg §¯ ß« 68.2% ÝGŒ. « ’ê³z BPE, EGF, « §¯  ßÑ _« îñG2 ak³ ¶æÊ

(45) ‰ƒÍ2 z_J¯ Áêõ ÷2 ak³ 0êŒ. Wang Ù[17]o BPE2

(46) ‰sF 0ê  ß¯Éˋ ÞY« Ê, )§¯  ßs ñ,G2 òOs G(O ,)§¯¯ šKH§ ¯‹  ßs ñ,G(2 :Ê, )§¯‹ ~dõ IgG2 ak³ ÝÊGk÷ 4) «aÑ ¬K _eK ÊÄ èn o é(( :Ê ÀŒ. K, BPE‹ 4Âô Æ o bovine pancreatic trypsin inhibitor(bPTI)sF T?U s-Ñ ‹g )§¯õ ¡¤K á 4 À2 T?U‹ l s IgO ¤ ÀÊ BPEÑ2 EGF  ~« WK æ´ À( :o ak³ ÝÊGŒ. Kamata Ù[18]o BPEÍ ƒÍ æ( :o å

(47) ‰ (‹  Î )§¯Í  ßG( :IÊ, BPE õ WKG( :2 å

(48) ‰ (ъ EGF, KGF, IGF-zê bFGF ç o  ß¯Éˋ ƒÍÍ )§¯‹  ßs ¿j ÉKŒÊ ÝÊ GŒ. 6÷ Cook Ù[19]o Ƌ foreskin )§¯‹  Î § ¯ ‰Í cm ¢ 5 10 í « ³ A peptide growth factorÍ Ç´‰ )§¯Í õJk³  ßGÊ, IGF, EGF, TGF-α, FGFõ Í³ ƒÍK  Î  ß‰õ ¿j àü( :IŒÊ ÝÊGŒ. «: Œ ñ ’ê2 )§¯Í  ßO A autocrine èn Ñ ‹K  A é«¶ O ¤ ÀÊ, U¾ EGF-R(EGF-receptor)Q a‹ -Ñà (ligands)Í autocrine[20, 21]ê paracrine  ßÆQ[22-24]Ñ y®K òOs G2 ak³ <s† ÀŒ. å

(49) ‰ (õ ÄG2  Î , )§¯Í ~WG2 «ˆ¯ òOs G2 EGFõ ¯WG2  ß¯ÉËê BPE ço 0Ës ƒÍg c´t G2 a« ³ä 271.8% 2+. 2+. 2. 3. Ÿ¤@¤ C43× C1ƒ 2005 2. Fig. 5. Effect of serum concentrations on the growth of normal rabbit oral keratinocytes. After the cultured keratinocyte had been harvested from primary confluence, 3.5×103/cm2 of cells were inoculated into T75-flask with 10 mL of K-SFM containing different serum concentrations. Supplements was used at the concentration of 50 mg/L BPE, 5.0 µg/L EGF and 1.5 mM Ca2+. Cell number was counted after 4 days of culture.. J«(O á õgъ2 «: )§¯‹ autocrine èn s Ê sGñ DáJ¯ ƒÍí³ Äæ2 BPE, EGF, Os ¬ k³ GŒ. D‹ Y×ъ

(50) ‰ƒÍÍ §¯ ßÑ z_J¯ s ÷ É2),

(51) ‰ ‰Ñ ¡dõ cÉs A‰ §¯ ßs IgG2(õ < 4ÝD .Gñ

(52) ‰ ‰Ñ ¡dõ c

(53) Š §¯ ßs Æ Gñ ÝI Œ. Fig. 5Ñ ÷ asF

(54) ‰ ‰Í ÍWÑ !¶ §¯ ßo à ¡dõ ÷( :IÊ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s WKK K-SFMÑ Wg 68.2% ÝGŒ. 6‚³

(55) ‰ƒ Í Ok³2 )§¯  ßs òO¾ K(GDÍ ´sÒ ak³ ¶ êŒ. ³äJk³ ,)§¯‹  ÎÑ2 (Ñ

(56) ‰s ƒÍGñ ŠGñt G(O )§¯‹  Î2

(57) ‰« 1¾s  ßs Ig GŒ. «: ’ê2 ¯Æ)‹ gÆ ,)§¯‹  Î

(58) î« Ë ´Q À(O )§¯b(

(59) î« ÊéG( :Ê ,)§¯Í  ß G

(60) Š ~WK «ˆ¯Ñ ‹g )§¯Í  ßñ,s ³kÿD AéÑ

(61) ‰o )§¯Ñ z_J¯ Áêõ ÷2 ak³ 0 êŒ. «6K «K³ )§¯õ ŠO A

(62) ‰s WKK (Ñ Š ,)§¯òOs G2 3T3 šKH§¯õ «ÄGñ feeder layerõ OÇ á  .Ñ )§¯õ ŠG2 D¬s ÄG2)[11], « öro  ß« µfê 3T3 §¯õ ] gWG2 a« Ä«G( : Ê, 3T3 §¯‹ @ʉ(viability)Í feeder³Š J¢G( :s ¤‰ Àk,

(63) ‰  ~Ë« šKH§¯õ ê‰Gj  ßQ ¤ Às O 4n¶,

(64) ‰ 0« ‚8_K  0s ÷D AéÑ )§¯‹  ß Ÿ8Ñ éfõ è@Q ¤‰ ÀŒ.

(65) ‰o ³äJ k³ Ÿí§¯ ŠÑŠ  ßs (òG2 òOs G2), DíL,  ß¯É, ’Y0(binding proteins)ço Qo  ~Ës fàG (O áº-4, K« ñ¶ K(mycoplasma), à«6) 1 ço ÙéJ¯ .×®¯s fàO ¤ ÀŒ.

(66) ‰o K k ¡~(batch) ¥³ ¡dÍ [GÊ, ¯Æ)s ŠO A ÄG2  Î2

(67) ò 2+.

(68) CãYL )§¯  ßÑ Âj h ¯É‹ . 107. Fig. 6. Effect of medium volume on the growth of normal rabbit oral keratinocytes. After the cultured keratinocyte had been harvested from primary confluence, 3.5×103/cm2 of cells were inoculated into T75-flask with K-SFM containing 50 mg/L BPE, 5.0 µg/L EGF, 1.5mM Ca2+ of different medium volume. Cell number was counted after 4 days of culture.. Fig. 7. Effect of Ca2+ concentrations on the growth of normal rabbit oral keratinocytes. After the cultured keratinocyte had been harvested from primary confluence, 3.5×103/cm2 of cells were inoculated into T75-flask with 10 mL of K-SFM containing 50 mg/L BPE, 5.0 µg/L EGF and different Ca2+ concentrations. Cell number was counted after 4 days of culture.. Mzä Ùs ÷ ¤ À2 Y« ÀŒ. «6K «K AéÑ é §¯ Šs .Gñ å

(69) ‰ (õ «ÄGs2 ök³ Mh GÊ ÀŒ. Fig. 6o Ÿ³K Š,

(70) J ÆQъ (z)Í )§¯  ß Ñ Âj2 s ÷ Öé¯), (z)Í 10 mL, 15 mL, 20 mL  ÍWÑ !¶ )§¯  ß« ÝG2 ’êõ ÷ Ɍ. «ao (z)Í ÍWÑ !¶ §¯Í ~WG2 «ˆ ¯‹ ‰õ ÝQÿD Aék³ 0êŒ. 6‚³ )§¯õ UGj RQÿ2 .gŠ2 (z)õ kñŠ ÄG2 a« §¯  ß‰õ ÍQÿ2) K-O ak³ ¶êŒ. )§¯  ßÑ Âj2  ‰‹ s Æ Gñ Fig. 7Ñ ÷. Ɍ.  ‰Í ÍO¤´ §¯  ß« ÍGk 2.0 mM. ‰ÑŠ MJjõ ÷Ɍ. Fig. 8o Î΋  ‰ÑŠ õ J¯ ª¬ Šs G

(71) Š passge number 2ъ‹   ,s ÷ a¯) §¯HŠo  ‰Í ÍO¤´ YY ‚è³Gj ¡dG2  s ÷Ɍ. « ‹ ’ê³ 0.1 mM‹ I ‰  ݌ 2.0 mM‹ Ê ‰‹ s WKK K-SFMъ §¯ ß« 76.9% ÍGÊ ÍQÑo 1.32³«ÉŒ. ä

(72)  ‰Í  ÍO¤´ §¯HŠ« ¡G2  s e¯O ¤ ÀɌ. Barbara Ù [25]o I ‰ s WKK å

(73) ‰ (ъ )§¯Í  ßK  Î §¯  ª

(74) « ÿˆÅÊ kÎ oQs Ý«2) «ao §¯Q §¯Ñ‹ zôDt‹ ’; Aék³ ’GÊ,  ‰Í Í. Fig. 8. Morphology of normal rabbit oral keratinocytes at passage number 2 cultured in T75-flask with 10 mL of K-SFM containing 50 mg/L BPE, 5 µg/L EGF and 0.1 mM Ca2+(a), 0.5 mM Ca2+(b), 1.0 mM Ca2+(c), 1.5 mM Ca2+(d), 2.0 mM Ca2+(e), and 2.5 mM Ca2+(f). Photographs at a magnification of ×100 were taken with a camera attached to a phase-contrast microscope at Day 4 after inoculation. Bar indicates 200 µm. Korean Chem. Eng. Res., Vol. 43, No. 1, February, 2005.

(75) Oéöáž_ö«åö߯öá_ö6ÎR. 108. O¤´ §¯Q §¯Ñ‹ õ’« ÆÊg(2 HŠs ÷É2) «ao  ‰Í ˆÃä1(cadherin)s ¯WG2 §¯ zô ~ É(intracellular adhesion molecules)‹ DDs l dGD Aék³ ÝÊGŒ. Ê ‰ ъ‹ §¯Q §¯Ñ õ’o P-ˆÃä1 ê E-ˆÃä1‹ ŽJÑ ‹K ak³ ½æÉÊ[26], «: ˆÃä 1‹ l d2 §¯Q §¯Ñ‹ õ’ O 4n¶ §¯‹ y@d (stratification)щ îñG2 ak³ <s† ÀŒ[27]. «6K §¯H Šs  G2 ao §¯Í ~dG

(76) Š Æ)ê ço gÆõ OËD .K ª³ 0êŒ. Fig. 8Ñ ÷   ,ъ  ‰ ¥³ §¯ HŠs WGGñ Ý

(77) «6K ÝÊQ K K as < ¤ ÀŒ. K,  ‰Í §¯ ßÑ Âj2 Ñ ¬gŠ2 Tsao Ù[14]o  ‰õ 1.0 mM WKGÊ À2 (ъ )§¯õ ŠK  Î §¯ ß« I¾ ÝG2 ak³ ÝÊGŒ. Kamata Ù[18]‰ )[ Æfg OÇ å 0 Y  ((protein-free synthetic medium)ъ 1.27 mM³  ‰õ ÆQK á Æ‹ gãYL )§¯õ ŠK ’ê  ß« M «P´(( :IÊ H& UM¾ ~dæÉŒÊ ÝÊGŒ. 6÷ BoyceQ Ham[28]‹ ÝÊÑ ‹G

(78)  ‰Í ÍO¤´ )§¯‹  ß« ÍG Ê 0.3 mMъ MJjõ ÷É(O 1.0 mM‹ Ê ‰ Ñ Љ BPEõ WKK å

(79) ‰ (‹  ÎÍ BPEõ WKG( :o  Î݌ §¯ ß« 900% « j ÷

(80) Œ. U¾ 1.0 mM‹ Ê ‰ ъ‰ §¯~dõ ÷2 ¯É¯ cornified envelopes õ ÷2 §¯Í BPEõ WKG( :o (‹  Î 20%õ Ý ¯ ä

(81) BPEõ WKK (‹  Î2 2% _‰õ ÷Ɍ. « ’ê2 å

(82) ‰ (ъ )§¯õ  ßQÿ2  Î BPEÍ Êé G

(83) Ê ‰ ъ‰ §¯ ß« ñ,î ¤ ÀŒ2 as ½G 2 É0³ 0êŒ. «Rj  ‰2 )§¯õ ŠO A   ßê ~d «Ñ ès K(Qÿ2 òOs G‚³ å

(84) ‰ (Ñ Š )§¯õ  ßQÿ2  Î J¢K Š‹  ‰õ -+G2 a« kÎ y®GŒ. á õgъ‰ BoyceQ Ham‹ ÝÊQ K÷Í (³  ‰Í ÍO¤´ )§¯  ß« ÍG2 ’êõ Ý Ê 2.0 mM‹ Ê ‰ ъ MJjõ ÷É2), «ao BPEÑ ‹K ‰ À(O ( .z)¢ §¯ ‰‹ ÍÑ ‹ Gñ autocrine DDÑ ‹g ~Wê «ˆ¯‹ ‰‰ ÍGñ §¯ ßs

(85) Ï ñ,QZD Aék³ 0êŒ. , ( .z) ¢ §¯ ‰Í ÍWÑ !¶ BPE, EGF, , «ˆ¯ê ço  ß¯Éˋ ‰‰ Gñ ÍGñt §¯  ß«

(86) Ï ñ, æ2 ak³ 0êŒ. 4.. û «. ً gãYLÆ)k³z )²f(dispase) ÁQ T?U Á~görs «ÄGñ YL )§¯õ ~-K ’ê YLÆ)k³z 1.92±0.59 10 í‹ @§¯(viable cell) õ ¡¤O ¤ ÀɌ. ¡¤K YL )§¯õ 2.6 10 í [ÜGñ 50 mg/L BPE, 5.0 µg/L EGF, 0.15 mM Ca ‹ K-SFMs 10 mL W KK T75-ñ¶)¿ÑŠ ³ó ŠK ’ê 8³ OÑ ŠÄDÑ § ¯Í ¯d(confluent)æj  ßGÊ, §¯¤2 2.5±0.3 10 í³ 9.6  ßGk ÍQÑo 2.45³«ÉŒ. ³ó ŠK §¯õ ¡¤K á T75-ñ¶)¿õ ÄGñ å

(87) ‰ (Q

(88) ‰ƒÍ (Ñ ¬K s Æ K ’ê K-SFMÑ ƒÍí³ 50 mg/L BPE, 5.0 µg/L. (trypsin) 0.25 cm2. 6. 5. 2+. 6. Ÿ¤@¤ C43× C1ƒ 2005 2. s WKK å

(89) ‰ (Í MEM, DMEM, F-12 (Ñ

(90) ‰s ƒÍK  Î݌ ÎÎ 37.5%, 106.3%, 112.9%b( §¯ ß« ÍGŒ. ( ƒÍíÑ ¬K s Æ Gñ á ’ê K-SFM Dá (ъ ŠK  ÎÑ Wg K-SFM Dá (Ñ 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s ƒÍK  ÎÍ 271.8% §¯ ß« Í GÊ, 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s ƒÍK K-SFMÑ 10%(v/v)

(91) ‰s

(92) ƒÍK  Î2 §¯  ß« 1¾s 33.3% ÝGŒ. K-SFM Dá (Ñ ƒÍí³ BPEQ EGFõ fŽGÊ 1.5 mM Ca ê 10%(v/v)

(93) ‰Os ƒÍ K  Î2 50 mg/L BPE, 5.0 µg/L EGF, 1.5 mM Ca s WKK K-SFM Ñ Wg §¯ ß« 68.2% ÝGŒ. K,

(94) ‰ ‰Í ÍWÑ !¶ §¯ ßo à ¡dõ ÷( :4Š

(95) ‰ƒÍ2 )§¯  ßÑ z_J¯ Áêõ ÷2 as e¯O ¤ ÀɌ. Ÿ³K Š,

(96) Jъ (z)Í ÍWÑ !¶ §¯ ßo ÝGÊ (z)õ 10 mL  ÄK  ÎÑ Wg 15 mL ÄK  Î 9%, 20 mL ÄK  Î 30%b( )§¯  ß« ÝGŒ. «ao (z)Í ÍO¤´ §¯ÑŠ ~Wæ2 «ˆ¯‹. ‰Í ÝGD Aék³ 0êŒ.  ‰Í ÍO¤´ §¯  ßo ÍGk 2.0 mM ‰ÑŠ M¬jõ ÷Ɍ. 0.1 mM ‹ I ‰ ݌ 2.0 mM‹ Ê ‰‹ s WKK K-SFMÑ Š §¯ ß« 76.9% ÍGŒ. « k³ Ù gãYL )§ ¯õ T75-ñ¶)¿õ «ÄGñ ŠG2  Î 50 mg/L BPE, 5.0 µg/L EGF, 2.0 mM Ca s WKK K-SFMs 10 mL ÄG2 h Æ Q« Íß JYGÊ, ÍQÑo 1.32³«ÉŒ. «6K õg’ê 2 á YL O 4n¶ )z, ÎL Ù ¯Ñ ÊéG2 )§¯ Šs .K à_íè«÷ @íäD ’ªÑ KÄK _Ýõ fà O ak³ 0êŒ. EGF, 1.5 mM Ca2+. 2+. 2+. 2+. 2+. 2+. [ ÷ á õg2 ÝQÞ(z ‹0àH aYD¬ íè Æ(êfdD 00(òÑ ‹g ¤}æÉk «Ñ Ý Ã?nŒ.. PJ1-PG1-CH12-0006). ƒ+S 1. Teichgraeber, J., Larson, D. and Castaneda, O., “Skin Grafts in Intraoral Reconstruction,” Arch. Otolaryngol., 110, 528-532(1984). 2. Schramm, V. L. and Myers, E. N., “Skin grafts in Oral Cavity Reconstruction,” Arch. Otolaryngol., 106, 528-532(1980). 3. Ueda, M., Ebata, K. and Kaneda, T., “In Vitro Fabrication of Bioartificial Mucosa for Reconstruction of oral Mucosa: Basic Research and Clinical Application,” Ann. Plast. Surg., 27(6), 540-549(1991). 4. Chase, D. C., Gattozzi, J. G. and Smith, K., “Palatal Graft in Preprosthetic Surgery,” Oral. Surg., 45, 516-527(1978). 5. Fry, T. L. and Woods, C. I., “Readily Available Full-Thickness Mucous Membrane Grafts,” Arch. Otolaryngol. Head Neck Surg., 113, 770-771(1987). 6. Hata, K., Kagami, H., Ueda, M., Torii, S. and Matsuyama M., “The Characteristics of Cultured Mucosal Cell Sheet as a Material for Grafting: Comparison with Cultured Epidermal Cell Sheet,” Ann. Plast. Surg., 34, 530-538(1995). 7. Izumi, K., Feinberg, S. E., Iida, A. and Yoshizawa, M., “Intraoral Grafting of an ex vivo Produced Oral Mucosa Equivalent: a Pre-.

(97) CãYL )§¯  ßÑ Âj h ¯É‹  liminary Report,” Int. J. Oral Maxillofac. Surg., 32, 188-197(2003). 8. Moriyama, T., Asahina, I., Ishii, M., Oda, M., Ishii, Y. and Enomoto, S., “Development of Composite Cultured Oral Mucosa Utilizing Collagen Sponge Matrix and Contracted Collagen Gel: a Preliminary Study for Clinical Applications,” Tissue Engineering, 7(4), 415-427(2001). 9. Fujiyama, C., Masaki, J. and Sugihara, H., “Reconstruction of the Urinary Bladder Mucosa in Three Dimensional Collagen Gel Culture: Fibroblast-Extracellular Matrix Interactions on the Differentiation of Transitional Epithelial Cells,” J. Urol., 153, 20602067(1995). 10. Ueda, M., Hata, K., Horie, K. and Torii, S. “The Potential of Oral Mucosal Cells for Cultured Epithelium: a Preliminary Report,” Ann. Plast. Surg., 35(5), 498-504(1995). 11. Rheinwald, J. C. and Green, H., “Serial Cultivation of Strains of Human Epidermal Keratinocytes: Formation of Keratinocyte Colonies From Single Cells,” Cell, 6, 331-343(1975). 12. Liu, S. C. and Karasek, M., “Isolation and Growth of Adult Human Epidermal Keratinocytes in Cell Culture,” J. Invest. Dermatol., 71, 157-162(1978). 13. Hennings, H., Michael, D., Cheng, C., Steinert, P., Holbrook, K. and Yuspa, S. H., “Calcium Regulation of Growth and Differentiation of Mouse Epidermal Cells in Culture,” Cell, 19, 245-254(1980). 14. Tsao, M. C., Walthall, B. J. and Ham, R. G., “Clonal Growth of Normal Epidermal Keratinocytes in Defined Medium,” J. Cell. Physiol., 110, 219-229(1982). 15. Hawley-Nelson, P., Sullivan, J. E., Kung, M., Hennings, H. and Yuspa, S. H., “Optimized Conditions for the Growth of Human Epidermal Cells in Culture,” J. Invest. Dermatol., 75, 176-182(1980). 16. Daniels, J. T., Kearney, J. N. and Ingham, E., “Human Keratinocyte Isolation and Cell Culture: a Survey of Current Practices in the UK,” Burns, 22, 35-39(1996). 17. Wang, H. J., Chen, T. M., Cheng, L. F., Cheng, T. Y. and Tung, Y. M., “Human Keratinocyte Culture using Porcine Pituitary Extract in Serum-Free Medium,” Burns, 21(7), 503-506(1995). 18. Kamata, N., Yokoyama, K., Fujimoto, R., Ueda, U., Hayashi, E., Nakanishi, H. and Nagayama, M., “Growth of Normal Oral Keratinocytes and Squamous Cell Carcinoma Cells in a Novel Protein-Free Defined Medium,” In Vitro Cell. Dev. Biol.-Animal, 35, 635-641(1999). 19. Cook, P. W., Pittelkow, M. R. and Shipley, G. D., “Growth Fac-. 109. tor-Independent Proliferation of Normal Human Keratinocytes: Production of Autocrine- and Paracrine-Acting Mitogenic Factors,” J. Cell. Physiol., 146, 277-289(1991). 20. Piepkorn, M., Lo, C. and Plowman, G., “Amphiregulin-Dependent Proliferation of Cultured Human Keratinocytes: Autocrine Growth, the Effects of Exogeneous Recombinant Cytokine, and Apparent Requirments for Heparin-Like Glycosaminoglycans,” J. Cell Physiol., 159, 114-120(1994). 21. Pittelkow, M. R., Cook, P. W., Shipley, G. D., Derynck, R. and Coffey, R. J., “Autonomous Growth of Human Keratinocytes Requires Epidermal Growth Factor Receptor Occupancy,” Cell Growth Differ., 4, 513-521(1993). 22. Dulgosz, A. A., Cheng, C., Dening, M. F., Dempsey, P. J., Coffey, R. J. and Yuspa, S. H., “Keratinocytes Growth Factor Receptor Ligands Induce Transforming Growth Factor Alpha Expression and Activate the Epidermal Growth Factor Receptor Signaling Pathway in Cultured Epidermal Keratinocytes,” Cell Growth Differ., 5, 1283-1292(1994). 23. Ristow, H. J., “Studies on Stimulation of DNA Synthesis with Epidermal Growth Factor and Insulin-Like Growth Factor-I in Cultured Human Keratinocytes,” Growth Regul., 6, 96-109(1996). 24. Vardy, D. A., Kari, C., Lazarus, G. S. and Jensen, P. J., Zilberstein, A., Plowman, G. D. and Rodeck, U., “Induction of Autocrine Epidermal Growth Factor Recepter Ligands in Human Keratinocytes by Insulin/Insulin-like Growth Factor-I,” J. Cell. Physiol., 163, 257-265(1995). 25. Marsh, B. C. R., Massaro-Giordano, M., Marshall, C. M., Lavker, R. M. and Jensen, P. J., “Initiation and Characterization of Keratinocyte Cultures from Biopsies of Normal Human Conjunctiva,” Exp. Eye Res., 74, 61-69(2002). 26. Wheelock, M. J. and Jensen, P. J., “Regulation of Keratinocyte Intercellular Junction Organization and Epidermal Morphogenesis by E-Cadherin,” J. Cell. Biol., 117, 415-425(1992). 27. O’Keefe, E. J., Briggaman, R. A. and Herman, B., “Calcium Induced Assembly of Adherens Junctions in Keratinocytes,” J. Cell. Biol., 105, 807-817(1987). 28. Boyce, S. T. and Ham, R. G., “Calcium-Regulated Differentiation of Normal Human Epidermal Keratinocytes in Chemically Defined Clonal Culture and Serum-Free Serial Culture,” J. Invest. Dermatol., 81, 33s-40s(1983).. Korean Chem. Eng. Res., Vol. 43, No. 1, February, 2005.

(98)

참조

관련 문서

http://blog.naver.com/op2330

그늘 에 주차된 자동차의 온도와 햇빛이 비치는 곳에 주차된 자동차의 온도가 다르다.. 불과 가까운 쪽에서 불에서 먼

l Drop metal ball into the water l Oil droplet come out from bottom of water.. 두 경우 모두 결국은 속도가

동결방지 조치를 취하여 등을 사용하여 적절한 우려가 있는 곳은 보온재 드레인 호스 설치시 동결.

[r]

[r]

&lt; 0.1 mg/L Penicillin G or ampicillin Cefotaxime, ceftriaxone, or chloramphenicol 0.1-1.0 mg/L Cefotaxime or ceftriaxone Cefepime, meropenem.. ≥ 2.0

 ´²  I]‚ ‡K  L˜ BBBBBBBBBBBBBBBBBBBBBBBB C.  ´², 0e